Anavex Life Sciences Corp (AVXL)

[Foosfund]

Falconer, many thanks to you and others for the educational and informative comments on the science and impact of Anavex. You use the term Blarcamesine which is a foreign name to most. As I understand it, Blarcamesine is merely another name for 2-73 which is the same basic drug used for all AVXL studies with different packaging, etc. If 2-73 works on one, it should (or may) work on other CNS diseases. As I further understand it, 3-71 may be the new and improved version of 2-73 in early testing. Is my very basic understanding correct?